Shares of UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) rose 0.6% during mid-day trading on Tuesday . The stock traded as high as $431.50 and last traded at $427.94. Approximately 3,133,965 shares changed hands during trading, a decline of 29% from the average daily volume of 4,395,431 shares. The stock had previously closed at $425.33.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on UNH. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating on the stock in a report on Wednesday. Mizuho raised their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Finally, Hsbc Global Res downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $603.05.
Check Out Our Latest Stock Report on UNH
UnitedHealth Group Stock Performance
The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock's 50-day moving average price is $503.28 and its 200 day moving average price is $534.62. The company has a market cap of $380.66 billion, a P/E ratio of 26.98, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the business earned $6.91 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.01%. UnitedHealth Group's dividend payout ratio is currently 35.18%.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Howard Capital Management Group LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at $341,000. Principal Financial Group Inc. grew its holdings in UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. McIlrath & Eck LLC raised its stake in shares of UnitedHealth Group by 8.2% in the third quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock worth $371,000 after acquiring an additional 48 shares during the last quarter. SOA Wealth Advisors LLC. lifted its position in shares of UnitedHealth Group by 3.7% during the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate's stock worth $746,000 after purchasing an additional 46 shares in the last quarter. Finally, Tudor Financial Inc. bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $900,000. 87.86% of the stock is owned by institutional investors.
About UnitedHealth Group
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
